Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
12/27/1996 | WO1996041876A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1996 | WO1996041639A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | WO1996041595A1 Process and device for the culture of bone replacement material |
12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
12/27/1996 | WO1996035784A3 Chromatin-regulator genes |
12/27/1996 | WO1996033214A3 Altered protein expression in hypoxic trophoblasts |
12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
12/27/1996 | EP0750040A2 Macrophage stimulating protein variant and method for producing the same |
12/27/1996 | EP0749981A1 Monoclonal antibody |
12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
12/27/1996 | EP0749491A1 Enhanced expression in a plant plastid |
12/27/1996 | EP0749490A1 EXPRESSION OF $i(BACILLUS THURINGIENSIS CRY) PROTEINS IN PLANT PLASTIDS |
12/27/1996 | EP0749481A1 Humanized monoclonal antibodies against human interleukin-4 |
12/27/1996 | EP0749480A1 Novel forms of t cells costimulatory molecules and uses therefor |
12/27/1996 | EP0749479A1 Novel thiol protease inhibitor |
12/27/1996 | EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
12/27/1996 | EP0749472A1 Extracorporeal cell culture and transplantation kits |
12/27/1996 | EP0749444A1 Hybrid human/animal factor viii |
12/27/1996 | EP0749443A1 Fk-506 cytosolic binding protein |
12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
12/27/1996 | EP0749323A1 Methods for modulating t cell unresponsiveness |
12/27/1996 | EP0749318A1 Method of stimulating hematopoiesis with hemoglobin |
12/27/1996 | EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | CA2221311A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1996 | CA2161391A1 Stable transformation |
12/25/1996 | CN1138863A Chimeric proteins which block complement activation |
12/24/1996 | US5587462 Corticotropin releasing factor; stimulates the secretion and biosynthesis of acth |
12/24/1996 | US5587460 Controller of cell differentiation; immunology |
12/24/1996 | US5587456 Hydrophobic attachment site for adhesion peptides |
12/24/1996 | US5587312 Somatic embryogenesis method |
12/24/1996 | US5587309 Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo |
12/24/1996 | US5587306 Dna sequences |
12/24/1996 | US5587302 T cell growth factor |
12/24/1996 | US5587299 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
12/24/1996 | US5587289 Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof |
12/24/1996 | US5587164 Vaccine for protection against porcine reproductive and respiratory disease |
12/19/1996 | WO1996041170A1 Monospecific antibodies against a subunit of fibrinogen |
12/19/1996 | WO1996041169A1 Functional bioassay for g-protein coupled receptor agonists and antagonists |
12/19/1996 | WO1996041163A1 Test system for determining the activity of natural killer cells |
12/19/1996 | WO1996040965A1 Synthetic mammalian chromosome and methods for construction |
12/19/1996 | WO1996040959A1 Cell line producing analgesic compounds for treating pain |
12/19/1996 | WO1996040958A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
12/19/1996 | WO1996040951A2 Use of ovary-tissue transcriptional factors |
12/19/1996 | WO1996040949A1 Induction of male sterility in plants by expression of high levels of avidin |
12/19/1996 | WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
12/19/1996 | WO1996040946A1 An autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
12/19/1996 | WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
12/19/1996 | WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
12/19/1996 | WO1996040937A2 Adenosine kinase polynucleotides |
12/19/1996 | WO1996040929A2 Transferrin receptor genes |
12/19/1996 | WO1996040925A2 Regulatory elements conferring tapetum specificity |
12/19/1996 | WO1996040924A2 Cotton fiber transcriptional factors |
12/19/1996 | WO1996040923A1 Macrophage derived chemokine and chemokine analogs |
12/19/1996 | WO1996040922A1 Novel serpin derived from human hypothalamus |
12/19/1996 | WO1996040921A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
12/19/1996 | WO1996040918A2 Novel cd40l mutein |
12/19/1996 | WO1996040916A1 Icam-4 materials and methods |
12/19/1996 | WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | WO1996040906A1 Optimized minizymes and miniribozymes and uses thereof |
12/19/1996 | WO1996040904A1 Secretion leader trap cloning method |
12/19/1996 | WO1996040894A1 Treatment of insulin resistance |
12/19/1996 | WO1996040889A1 Method for spatially positioning cells within a three-dimensional matrix |
12/19/1996 | WO1996040887A1 Immunoprotective barrier for transplantation of cells |
12/19/1996 | WO1996040881A1 Fucosyltransferase genes and uses thereof |
12/19/1996 | WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
12/19/1996 | WO1996040877A1 Immortalization and disimmortalization of cells |
12/19/1996 | WO1996040876A1 Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
12/19/1996 | WO1996040875A1 Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
12/19/1996 | WO1996040874A1 Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
12/19/1996 | WO1996040873A1 Standardized, primary osteoblast cell cultures taken from patients suffering from osteoporosis, and the use of these cell cultures in the diagnosis of osteoporosis and for testing potential osteoporosis therapeutic agents |
12/19/1996 | WO1996040872A1 Bile duct progenitor cells and methods of use |
12/19/1996 | WO1996040870A1 Dual fiber bioreactor |
12/19/1996 | WO1996040868A1 Essential oligonucleotides of vertebrate telomerase |
12/19/1996 | WO1996040867A1 Recombinant viral nucleic acids |
12/19/1996 | WO1996040866A1 Serum-free media for primitive hematopoietic cells and methods of use thereof |
12/19/1996 | WO1996040864A1 A novel protein, faf1, which potentiates fas-mediated apoptosis and uses thereof |
12/19/1996 | WO1996040858A1 Apparatus and method for maintaining and growing biological cells |
12/19/1996 | WO1996040829A1 Crosslinkable polypeptide compositions |
12/19/1996 | WO1996040788A1 Anti-allergy bispecific molecules |
12/19/1996 | WO1996040771A1 SINGLE CHAIN ANALOGS OF THE TGF-β SUPERFAMILY (MORPHONS) |
12/19/1996 | WO1996040769A1 Developmentally-regulated endothelial cell locus-1 |
12/19/1996 | WO1996040766A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
12/19/1996 | WO1996040762A1 Monocyte chemotactic protein-4 |
12/19/1996 | WO1996040724A1 Recombinational cloning using engineered recombination sites |
12/19/1996 | WO1996040721A1 A cytotoxicity-based genetic selection system (toxsel) |
12/19/1996 | WO1996040719A1 Endothelial-monocyte activating polypeptide iii |
12/19/1996 | WO1996040657A1 Inhibitors of phospholipase a¿2? |
12/19/1996 | WO1996040304A1 Injectable hydrogel compositions |
12/19/1996 | WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
12/19/1996 | WO1996040272A1 Aav transduction of myoblasts |
12/19/1996 | WO1996040270A1 In vitro packaging of adeno-associated virus dna |
12/19/1996 | WO1996040269A1 INCREASING rAAV TITER |
12/19/1996 | WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens |
12/19/1996 | WO1996040252A1 High affinity human monoclonal antibodies specific for rsv f-protein |